6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: not found
          • Article: not found

          World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

          (2013)
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

              To create a valid, sensitive, disease-specific health status measure for patients with congestive heart failure (CHF). Quantifying health status is becoming increasingly important for CHF. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire that quantifies physical limitations, symptoms, self-efficacy, social interference and quality of life. To establish the performance characteristics of the KCCQ, two distinct patient cohorts were recruited: 70 stable and 59 decompensated CHF patients with ejection fractions of <40. Upon entry into the study, patients were administered the KCCQ, the Minnesota Living with Heart Failure Questionnaire and the Short Form-36 (SF-36). Questionnaires were repeated three months later. Convergent validity of each KCCQ domain was documented by comparison with available criterion standards (r = 0.46 to 0.74; p < 0.001 for all). Among those with stable CHF who remained stable by predefined criteria (n = 39), minimal changes in KCCQ domains were detected over three months of observation (mean change = 0.8 to 4.0 points, p = NS for all). In contrast, large changes in score were observed among patients whose decompensated CHF improved three months later (n = 39; mean change = 15.4 to 40.4 points, p < 0.01 for all). The sensitivity of the KCCQwas substantially greater than that of the Minnesota Living with Heart Failure and the SF-36 questionnaires. The KCCQis a valid, reliable and responsive health status measure for patients with CHF and may serve as a clinically meaningful outcome in cardiovascular research, patient management and quality assessment.
                Bookmark

                Author and article information

                Journal
                JAMA Cardiology
                JAMA Cardiol
                American Medical Association (AMA)
                2380-6583
                March 24 2021
                Affiliations
                [1 ]Duke Clinical Research Institute, Durham, North Carolina
                [2 ]Division of Cardiology, Duke University School of Medicine, Durham, North Carolina
                [3 ]Department of Medicine, University of Mississippi Medical Center, Jackson
                [4 ]Saint Luke’s Mid America Heart Institute and the University of Missouri–Kansas City, Kansas City
                [5 ]Brigham and Women’s Hospital Heart and Vascular Center and Harvard Medical School, Boston, Massachusetts
                [6 ]Nursing Institute and Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, Ohio
                [7 ]Novartis Pharmaceuticals Corporation, East Hanover, New Jersey
                [8 ]Eshelman School of Pharmacy, University of North Carolina, Chapel Hill
                [9 ]Assistant Editor for Statistics, JAMA Cardiology
                [10 ]Mended Hearts, Huntsville, Alabama
                [11 ]Associate Editor, JAMA Cardiology
                [12 ]Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, Los Angeles
                [13 ]Associate Editor for Health Care Quality and Guidelines, JAMA Cardiology
                Article
                10.1001/jamacardio.2021.0372
                33760037
                643ae033-f38c-4462-a5b5-2e385f3f0ec5
                © 2021
                History

                Comments

                Comment on this article